CA2699491A1 - Infectious disease testing of menstrual fluid, endometrial/menstrual cells, amniotic fluid, umbilical cord blood or other samples - Google Patents

Infectious disease testing of menstrual fluid, endometrial/menstrual cells, amniotic fluid, umbilical cord blood or other samples Download PDF

Info

Publication number
CA2699491A1
CA2699491A1 CA2699491A CA2699491A CA2699491A1 CA 2699491 A1 CA2699491 A1 CA 2699491A1 CA 2699491 A CA2699491 A CA 2699491A CA 2699491 A CA2699491 A CA 2699491A CA 2699491 A1 CA2699491 A1 CA 2699491A1
Authority
CA
Canada
Prior art keywords
human
sample
fluid
infectious disease
testing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2699491A
Other languages
English (en)
French (fr)
Inventor
Mercedes A. Walton
Julie G. Allickson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cryo Cell International Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2699491A1 publication Critical patent/CA2699491A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/571—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses for venereal disease, e.g. syphilis, gonorrhoea
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/26—Infectious diseases, e.g. generalised sepsis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA2699491A 2007-09-14 2008-09-15 Infectious disease testing of menstrual fluid, endometrial/menstrual cells, amniotic fluid, umbilical cord blood or other samples Abandoned CA2699491A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US99374807P 2007-09-14 2007-09-14
US60/993,748 2007-09-14
US19160108P 2008-09-09 2008-09-09
US61/191,601 2008-09-09
PCT/US2008/010751 WO2009035706A1 (en) 2007-09-14 2008-09-15 Infectious disease testing of menstrual fluid, endometrial /menstrual cells, amniotic fluid, umbilical cord blood or other samples

Publications (1)

Publication Number Publication Date
CA2699491A1 true CA2699491A1 (en) 2009-03-19

Family

ID=40452371

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2699491A Abandoned CA2699491A1 (en) 2007-09-14 2008-09-15 Infectious disease testing of menstrual fluid, endometrial/menstrual cells, amniotic fluid, umbilical cord blood or other samples

Country Status (15)

Country Link
EP (1) EP2200620A4 (es)
JP (1) JP2010539479A (es)
KR (1) KR20100063089A (es)
CN (1) CN101854942A (es)
AR (1) AR068449A1 (es)
AU (1) AU2008299884A1 (es)
BR (1) BRPI0817333A2 (es)
CA (1) CA2699491A1 (es)
CL (1) CL2008002749A1 (es)
CR (1) CR11315A (es)
EC (1) ECSP10010048A (es)
MX (1) MX2010002910A (es)
NI (1) NI201000037A (es)
TW (1) TW200918020A (es)
WO (1) WO2009035706A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2916520A1 (en) * 2013-07-03 2015-01-08 Coyne Ip Holdings, Llc Methods for predicting responses to chemical or biologic substances
GB2543728B (en) 2014-08-12 2019-04-17 Nextgen Jane Inc Medical kit and method for processing a biological sample
WO2017180909A1 (en) 2016-04-13 2017-10-19 Nextgen Jane, Inc. Sample collection and preservation devices, systems and methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5725481A (en) * 1996-05-17 1998-03-10 A. Fem Medical Corporation Method and apparatus for collecting vaginal fluid and exfoliated vaginal cells for diagnostic purposes
US7638093B2 (en) * 2004-01-28 2009-12-29 Dnt Scientific Research, Llc Interrupted flow rapid confirmatory immunological testing device and method
US20080241113A1 (en) * 2007-03-01 2008-10-02 Cryo-Cell International, Inc. Procurement, isolation and cryopreservation of endometrial/menstrual cells

Also Published As

Publication number Publication date
EP2200620A4 (en) 2010-10-27
KR20100063089A (ko) 2010-06-10
AU2008299884A1 (en) 2009-03-19
AR068449A1 (es) 2009-11-18
BRPI0817333A2 (pt) 2017-06-13
CR11315A (es) 2010-08-13
WO2009035706A1 (en) 2009-03-19
CL2008002749A1 (es) 2010-05-07
MX2010002910A (es) 2010-05-24
ECSP10010048A (es) 2010-06-29
NI201000037A (es) 2011-06-21
JP2010539479A (ja) 2010-12-16
EP2200620A1 (en) 2010-06-30
CN101854942A (zh) 2010-10-06
TW200918020A (en) 2009-05-01

Similar Documents

Publication Publication Date Title
US5447837A (en) Multi-immunoassay diagnostic system for antigens or antibodies or both
EP0216191B1 (en) Immunoassay for htlv-iii antigens
Lien et al. Evaluation of rapid diagnostic tests for the detection of human immunodeficiency virus types 1 and 2, hepatitis B surface antigen, and syphilis in Ho Chi Minh City, Vietnam.
US20090104650A1 (en) Infectious diseases testing of menstrual fluid, endometrial/menstrual cells, amniotic fluid, umbilical cord blood or other samples
JPH03502241A (ja) ヒト血清におけるｈｉｖ抗原を検出する酵素免疫検定法
Voordouw et al. Performance of Zika assays in the context of Toxoplasma gondii, parvovirus B19, rubella virus, and cytomegalovirus (TORCH) diagnostic assays
AU3945893A (en) Assay for detection of HIV antigen and HIV antibody
WO1988007680A1 (en) Immunoglobulin assay method
FI90801B (fi) Menetelmä anti-HIV:n määrittämiseksi, tarvikkeet sitä varten ja niiden käyttö tässä menetelmässä
JPH11148936A (ja) イムノアッセイ及びそれを行うキット
Chou et al. Immunoglobulin M to cytomegalovirus in primary and reactivation infections in renal transplant recipients
CA2699491A1 (en) Infectious disease testing of menstrual fluid, endometrial/menstrual cells, amniotic fluid, umbilical cord blood or other samples
JPH0743384B2 (ja) アッセイ用水性洗浄液、診断試験キット及び単純ヘルペスウイルスの測定方法
CN101368964A (zh) 一种检测巨细胞病毒IgG抗体的化学发光法免疫分析诊断试剂盒
EP0196873B1 (en) Diagnostic testing for micro-organisms
WO2008104081A1 (en) Parallel immunoassay device
CN116500260A (zh) 免疫缺陷病毒抗原和抗体快速定性检测的试纸条、检测卡及检测方法
EP1135684B1 (en) IMPROVED SPECIFICITY IN THE DETECTION OF ANTI-RUBELLA IgM ANTIBODIES
Sommerfelt et al. A simple semi-rapid HIV-1&2 confirmatory immunoassay using magnetic particles
RU2283497C1 (ru) ИММУНОФЕРМЕНТНАЯ ТЕСТ-СИСТЕМА ДЛЯ ИДЕНТИФИКАЦИИ СПЕКТРА АНТИТЕЛ К ВИЧ 1 И 2 ВЫЯВЛЕНИЯ АНТИГЕНА ВИЧ 1 (p24) "ДС-ИФА-АНТИ-ВИЧ 1 И 2, ВИЧ 1 ГРУППЫ О-СПЕКТР+АГ p24 ВИЧ 1"
Kaore Laboratory diagnosis of scrub typhus
RU2752862C1 (ru) Штамм hCoV-19/Russia/Omsk-202118-1707/2020 коронавируса SARS-CoV-2, иммуносорбент, содержащий цельновирионный очищенный антиген, полученный на основе указанного штамма и тест-система ИФА для выявления антител классов M, G и A к коронавирусу SARS-CoV-2 с использованием указанного иммуносорбента
ZA200109790B (en) Assay.
WO2011022445A2 (en) Improved multiplexed, microparticle-based assay for antibodies to antigens
EP0302154A1 (en) Detection of HIV and anti-lymphocyte antibodies

Legal Events

Date Code Title Description
FZDE Dead

Effective date: 20130917